Wolverine Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $304K | Sell |
1,400
-64,500
| -98% | -$14.3M | ﹤0.01% | 1025 |
|
|
2025
Q4 | $15.1M | Sell |
65,900
-24,300
| -27% | -$5.54M | 0.12% | 178 |
|
|
2025
Q3 | $20.9M | Buy |
90,200
+13,700
| +18% | +$2.79M | 0.15% | 135 |
|
|
2025
Q2 | $14.2M | Buy |
76,500
+50,400
| +193% | +$9.37M | 0.13% | 175 |
|
|
2025
Q1 | $5.47M | Buy |
26,100
+8,500
| +48% | +$1.65M | 0.07% | 286 |
|
|
2024
Q4 | $3.13M | Buy |
17,600
+17,400
| +8,700% | +$3.2M | 0.03% | 409 |
|
|
2024
Q3 | $39.5K | Sell |
200
-11,800
| -98% | -$2.2M | ﹤0.01% | 1202 |
|
|
2024
Q2 | $2.06M | Sell |
12,000
-6,000
| -33% | -$994K | 0.02% | 497 |
|
|
2024
Q1 | $3.28M | Sell |
18,000
-91,900
| -84% | -$15.8M | 0.04% | 378 |
|
|
2023
Q4 | $17M | Sell |
109,900
-700
| -0.6% | -$102K | 0.15% | 170 |
|
|
2023
Q3 | $16.5M | Buy |
110,600
+37,300
| +51% | +$5.48M | 0.19% | 134 |
|
|
2023
Q2 | $9.88M | Sell |
73,300
-41,400
| -36% | -$6.07M | 0.12% | 180 |
|
|
2023
Q1 | $18.3M | Buy |
114,700
+86,700
| +310% | +$13.3M | 0.22% | 130 |
|
|
2022
Q4 | $4.53M | Buy |
28,000
+27,500
| +5,500% | +$4.22M | 0.05% | 368 |
|
|
2022
Q3 | $67K | Buy |
+500
| New | +$71.7K | ﹤0.01% | 1524 |
|
|
2018
Q2 | – | Sell |
-43,200
| Closed | -$4.09M | – | 1368 |
|
|
2018
Q1 | $4.09M | Buy |
43,200
+33,200
| +332% | +$3.65M | 0.05% | 308 |
|
|
2017
Q4 | $967K | Hold |
10,000
| – | – | 0.01% | 736 |
|
|
2017
Q3 | $888K | Hold |
10,000
| – | – | 0.01% | 697 |
|
|
2017
Q2 | $725K | Sell |
10,000
-20,800
| -68% | -$1.4M | 0.01% | 699 |
|
|
2017
Q1 | $2.01M | Sell |
30,800
-1,600
| -5% | -$101K | 0.03% | 396 |
|
|
2016
Q4 | $2.03M | Hold |
32,400
| – | – | 0.03% | 395 |
|
|
2016
Q3 | $2.04M | Hold |
32,400
| – | – | 0.03% | 399 |
|
|
2016
Q2 | $2M | Buy |
32,400
+32,076
| +9,900% | +$1.95M | 0.03% | 437 |
|
|
2016
Q1 | $106K | Hold |
324
| – | – | ﹤0.01% | 767 |
|
|
2015
Q4 | $118K | Buy |
324
+250
| +338% | +$14.4K | ﹤0.01% | 969 |
|
|
2015
Q3 | $68K | Hold |
74
| – | – | ﹤0.01% | 1186 |
|
|
2015
Q2 | $29K | Buy |
+74
| New | +$4.83K | ﹤0.01% | 1408 |
|
|
2015
Q1 | – | Sell |
-372
| Closed | -$3K | – | 1793 |
|
|
2014
Q4 | $3K | Buy |
372
+67
| +22% | +$4.22K | ﹤0.01% | 1910 |
|
|
2014
Q3 | $38K | Hold |
305
| – | – | ﹤0.01% | 1612 |
|
|
2014
Q2 | $70K | Buy |
+305
| New | +$16K | ﹤0.01% | 1277 |
|
|
2013
Q3 | – | Sell |
-1
| Closed | -$1K | – | 2653 |
|
|
2013
Q2 | $1K | Buy |
+1
| New | +$44 | ﹤0.01% | 2550 |
|
Other funds holding ABBV
VCM
VPM
Wolverine Asset Management's ABBV Position: Q3 2025 in Review
Wolverine Asset Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 21,256 shares — an estimated $4.33M sold.
Wolverine Asset Management first reported a position in ABBV in Q2 2013 and held it in 25 quarters. The position peaked at $7.78M in Q2 2023. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Wolverine Asset Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- Wolverine Asset Management sold 21,256 AbbVie shares in Q3 2025, an estimated $4.33M.
- Wolverine Asset Management first reported a position in AbbVie in Q2 2013 and held it in 25 quarters.
- Wolverine Asset Management's AbbVie position peaked at $7.78M in Q2 2023.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.